“…The number of Medicare beneficiaries diagnosed with ADRD increased dramatically during the 1990s, possibly because of newer diagnostic approaches, particularly PET, and increased availability of prescription drugs to treat the condition (e.g., cholinesterase inhibitors, atypical antipsychotics) (Taylor, Fillenbaum, and Ezell 2002). In our sample, 8.9% of Medicare beneficiaries were diagnosed with ADRD in 1994, and 18.0% in 1999.…”